BackSilexion Therapeutics Overview

Silexion Therapeutics Current Cash

Latest current cash for SLXN: $2.2M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.23M
↓ 35.69% YoYΔ $-1.24M vs prior year quarter

Peer trimmed avg / median

Loading

Silexion Therapeutics Current Cash History

Loading

Silexion Therapeutics vs. peers: Current Cash Comparison

Loading

Silexion Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Silexion Therapeutics (SLXN) FAQ

Silexion Therapeutics (SLXN) currently reports a current cash of $2.2M as of June 2026. That compares with $3.5M in the prior-year period — down 35.7% year over year. Use the charts on this page to explore Silexion Therapeutics's current cash history and peer comparisons.

Silexion Therapeutics's current cash decreased from $3.5M to $2.2M — a 35.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Silexion Therapeutics reported $2.2M in current cash as of June 2026. That compares with $3.5M in the prior-year period — down 35.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Silexion Therapeutics, and consider following SLXN for alerts when major investors trade the stock.